Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium

Vaccine

Volumn 17, Issue 15-16, 1999, Pages 1942-1950

  Voeten, J T M ^a   Brands, R ^b   Palache, A M ^b   Van Scharrenburg, G J M ^b   Rimmelzwaan, G F ^a   Osterhaus, A D M E ^a   Claas, E C J ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

Influenza; MDCK cell; Reassortment

Indexed keywords

INFLUENZA VACCINE;

ANIMAL CELL; ARTICLE; CELL STRAIN; DOG; GROWTH REGULATION; INFLUENZA VIRUS A; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VACCINE PRODUCTION; VIROGENESIS; VIRUS VIRULENCE;

ANIMALS; CELL LINE; CULTURE MEDIA, SERUM-FREE; DOGS; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTINATION TESTS; HEMAGGLUTININS, VIRAL; INFLUENZA A VIRUS; MEMBRANE GLYCOPROTEINS; NEURAMINIDASE; REASSORTANT VIRUSES; RESTRICTION MAPPING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; VIRAL MATRIX PROTEINS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0033537974     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00464-2     Document Type: Article

References (23)

1. de Jong J.C., Claas E.C.J., Osterhaus A.D.M.E., Webster R.G., Lim W.L. A pandemic warning? Nature. 389:1997;554.
2. Claas E.C.J., Osterhaus A.D.M.E., van Beek R., De Jong J.C., Rimmelzwaan G.F., Senne D.A., Krauss S., Shortridge K., Webster R.G. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet. 351:1998;472-477.
3. Robertson J.S., Bootman J.S., Nicolson C., Major D., Robertson E.W., Wood J.M. The hemagglutinin of influenza B virus present in clinical material is a single species identical to that of mammalian cell-grown virus. Virology. 179:1990;35-40.
4. Wang M., Katz J.M., Webster R.G. Extensive heterogeneity in the hemagglutinin of egg-grown influenza viruses from different patients. Virology. 171:1989;275-279.
5. Robertson J.S., Cook P., Nicolson C., Newman R., Wood J.M. Mixed populations in influenza virus vaccine strains. Vaccine. 12:1994;1317-1320.
6. Gubareva L.V., Wood J.M., Meyer W.J., Katz J.M., Robertson J.S., Major D., Webster R.G. Codominant mixtures of viruses in reference strains of influenza virus due to host cell variation. Virology. 199:1994;89-97.
7. Schild G.C., Oxford J.S., de Jong J.C., Webster R.G. Evidence for host-cell selection of influenza virus antigenic variants. Nature. 303:1983;706-709.
8. Robertson J.S., Bootman J.S., Newman R., Oxford J.S., Daniels R.S., Webster R.G., Schild G.C. Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus. Virology. 160:1987;31-37.
9. Kodihalli S., Justewicz D.M., Gubareva L.V., Webster R.G. Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective. J. Virol. 69:1995;4888-4897.
10. Brands R, Palache AM, van Scharrenburg GJM. Madin Darby Canine Kidney (MDCK)-cells for the production of inactivated influenza subunit vaccine. Safety characteristics and clinical results in the elderly. In: Brown LE, Hampson AW, Webster RG, editors. Options for the control of influenza III. Amsterdam: Elsevier, 1996. p. 683-93.
11. Brands R, Palache AM, van Scharrenburg GJM. Development of influenza subunit vaccine produced using mammalian cell culture technology. In: Carrondo MJT, Griffiths B, Moreira JLP, editors. Animal cell technology: from vaccines to genetic medicine. Dordrecht: Kluwer Academic Publishers, 1997. p. 165-7.
12. Palache A.M., Brands R., van Scharrenburg G.J.M. Immunogenicity and reactogenicity of influenza subunit vaccines produced in MDCK cells or fertilized chicken eggs. J. Infect. Dis. 176:1997;S20-S23.
13. Claas E.C.J., Sprenger M.J.W., Kleter G.E.M., van Beek R., Quint W.G.W., Masurel N. Type-specific identification of influenza A, B and C by the polymerase chain reaction. J. Virol. Methods. 39:1992;1-13.
14. Klimov A.I., Cox N.J. PCR restriction analysis of genome composition and stability of cold-adapted reassortant live influenza vaccines. J. Virol. Methods. 52:1995;41-49.
15. Sakamoto S., Kino Y., Oka T., Herlocher M.L., Maassab M.L. Gene analysis of reassortant influenza virus by RT-PCR followed by restriction enzyme digestion. J. Virol. Methods. 56:1996;161-171.
16. Yasuda J., Toyoda T., Nakayama M., Ishihama A. Regulatory effects of matrix protein variations on influenza virus growth. Arch. Virol. 133:1993;283-294.
17. Yasuda J., Bucher D., Ishihama A. Growth control of influenza A virus by M1 protein: analysis of transfectant viruses carrying the chimeric M gene. J. Virol. 68:1994;8141-8146.
18. Xu X., Kilbourne E.D., Hall H.E., Cox N.J. Nonimmunoselected intrastrain genetic variation detected in pairs of high yielding influenza A (H3N2) vaccine and parental viruses. J. Infect. Dis. 170:1994;1432-1438.
19. Smeenk C.A., Brown E.G. The influenza virus variant A/FM/1/47-MA possesses single amino acid replacements in the hemagglutinin, controlling virulence, and in the matrix protein, controlling virulence as well as growth. J. Virol. 68:1994;530-534.
20. Cox N.J., Maassab H.F., Kendal A.P. Comparative study of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25°C between recent H3N2 and H1N1 epidemic strains and cold-adapted A/Ann Arbor/6/60. Virology. 97:1979;190-194.
21. Kaverin N.V., Rudneva I.A., Smirnov A., Finskaya N.N. Human-avian influenza virus reassortants: effect of reassortment pattern on multi-cycle reproduction in MDCK cells. Arch. Virol. 103:1988;117-126.
22. Rudneva I.A., Kovaleva V.P., Varich N.L., Farashyan V.R., Gubareva L.V., Yamnikova S.S., Popova I.A., Presnova V.P., Kaverin N.V. Influenza A virus reassortants with surface glycoprotein genes of the avian parent viruses: effects of HA and NA gene combinations on virus aggregation. Arch. Virol. 133:1993;437-450.
23. Horaud F. Viral vaccines and residual cellular DNA. Biologicals. 23:1995;225-228.